<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02143544</url>
  </required_header>
  <id_info>
    <org_study_id>Heart Institute</org_study_id>
    <nct_id>NCT02143544</nct_id>
  </id_info>
  <brief_title>Intra-aortic Balloon Counterpulsation in Patients Undergoing Cardiac Surgery</brief_title>
  <acronym>IABCS</acronym>
  <official_title>Intra-aortic Balloon Counterpulsation in Patients Undergoing Cardiac Surgery: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Sao Paulo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Sao Paulo</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The hypothesis of the study is to evaluate if the preoperative placement of IABP reduces
      clinical complications in high-risk patients undergoing cardiac surgery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      High-risk patients undergoing cardiac surgery are at high risk for myocardial ischemia,
      arrhythmia, cardiogenic shock and other clinical complications. Different therapeutic options
      are available to support these patients in the perioperative period including inotropes,
      vasopressors, and vasodilators, and also assist devices such as intra-aortic balloon pump
      (IABP) and others.

      IABP increases myocardial oxygen supply by increasing diastolic coronary perfusion pressure
      and decreases myocardial oxygen demand by reducing left ventricular afterload. Additionally,
      IABP can also improve cardiac output and systemic perfusion. The hypothesis of this
      randomized and controlled trial is that the placement of IABP immediately before the cardiac
      surgery reduces clinical complications in high-risk patients.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">April 2016</completion_date>
  <primary_completion_date type="Anticipated">April 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite 30-day mortality or major morbidity (mechanical ventilation &gt; 24 hours, mediastinitis, surgical reexploration, stroke, cardiogenic shock, acute renal failure)</measure>
    <time_frame>30 days</time_frame>
    <description>Composite outcome of 30-day mortality or incidence of patients presenting a major complication according to modified Society of Thoracic Surgeons (STS): mechanical ventilation &gt; 24 hours, deep sternal wound infection/mediastinitis, surgical reexploration, stroke, cardiogenic shock and acute renal failure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of mechanical ventilation</measure>
    <time_frame>30 days</time_frame>
    <description>Number of days during mechanical ventilation.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IABP complications</measure>
    <time_frame>30 days</time_frame>
    <description>Number of patients presenting one of the following: lower limb ischemia, mesenteric ischemia or bleeding.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Use of vasoactive agents</measure>
    <time_frame>30 days</time_frame>
    <description>Number of days and dose of inotropes and vasopressors.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluation of hemodynamic data</measure>
    <time_frame>48 hours</time_frame>
    <description>Comparison of the following hemodynamic data between groups: heart rate, arterial pressure and cardiac output.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Levels of biomarkers</measure>
    <time_frame>7 days</time_frame>
    <description>Comparison of the following biomarker levels between groups: pro-BNP (Brain natriuretic peptide), troponin I and Neutrophil gelatinase-associated lipocalin (NGAL), Heart-type Fatty Acid Binding Protein (H-FABP)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Echocardiographic parameters</measure>
    <time_frame>7 days</time_frame>
    <description>Comparison of the following echocardiographic parameters between groups: left ventricular ejection fraction, cardiac output, left ventricular diastolic diameter, left ventricular systolic diameter and wall motion abnormalities.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30-day mortality</measure>
    <time_frame>30 days</time_frame>
    <description>Death during hospital stay or death after hospital discharge until 30 days following the procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>60-days mortality</measure>
    <time_frame>60 days</time_frame>
    <description>Death until 60 days following the procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>1-year mortality</measure>
    <time_frame>1 year</time_frame>
    <description>Death until 1 year following the procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Costs</measure>
    <time_frame>30 days</time_frame>
    <description>Comparison of overall costs between groups.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Acute Kidney Injury</measure>
    <time_frame>30 days</time_frame>
    <description>Incidence of acute kidney injury according the Acute Kidney Injury Network (AKIN) classification.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiovascular complications</measure>
    <time_frame>30 days</time_frame>
    <description>Arrhythmias or myocardial ischemia within 30 days after randomization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infectious complications</measure>
    <time_frame>30 days</time_frame>
    <description>New infection or septic shock within 30 days after randomization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Delirium</measure>
    <time_frame>30 days</time_frame>
    <description>Acute cognitive dysfunction diagnosed with the use of the CAM-ICU scale within 30 days after randomization</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding</measure>
    <time_frame>24 hours</time_frame>
    <description>Blood losses exceeding 100-300 mL per hour following ICU admission</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">180</enrollment>
  <condition>Postoperative; Dysfunction Following Cardiac Surgery</condition>
  <arm_group>
    <arm_group_label>Preoperative intra-aortic balloon pump.</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intervention: Preoperative placement of the intra-aortic balloon pump.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No preoperative placement of the intra-aortic balloon pump.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Intra-aortic balloon pump.</intervention_name>
    <description>Preoperative placement of the intra-aortic balloon pump.</description>
    <arm_group_label>Preoperative intra-aortic balloon pump.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age equal to or higher than 18 years old

          -  EuroSCORE equal to or higher than 6 or ejection fraction equal to or lower than 40%

          -  Written informed consent

        Exclusion Criteria:

          -  Cardiogenic shock

          -  Acute myocardial infarction (AMI) &lt; 48 hours

          -  Mechanical complications of AMI

          -  Peripheral vascular disease (aorta, iliac or femoral)

          -  Severe aortic regurgitation

          -  Neoplasm

          -  Pregnancy

          -  Tachyarrhythmia

          -  Procedures of the aorta

          -  Coagulopathy

          -  Thrombocytopenia

          -  Cardiac transplantation, congenital heart disease or endocarditis

          -  Refusal to consent
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ludhmila A Hajjar, PhD</last_name>
    <phone>11-26625232</phone>
    <email>ludhmila@usp.br</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Graziela Ferreira, Dr</last_name>
    <phone>11-26615367</phone>
    <email>gsrf@uol.com.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Heart Institute</name>
      <address>
        <city>Sao Paulo</city>
        <state>SP</state>
        <zip>05403000</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ludhmila A Hajjar, PhD</last_name>
      <phone>11-26615232</phone>
      <email>ludhmila@usp.br</email>
    </contact>
    <contact_backup>
      <last_name>Graziela Ferreira, Dr</last_name>
      <phone>11-26615367</phone>
      <email>gsrf@uol.com.br</email>
    </contact_backup>
    <investigator>
      <last_name>Ludhmila A Hajjar, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>February 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 30, 2014</study_first_submitted>
  <study_first_submitted_qc>May 18, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 21, 2014</study_first_posted>
  <last_update_submitted>February 3, 2016</last_update_submitted>
  <last_update_submitted_qc>February 3, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 4, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Sao Paulo</investigator_affiliation>
    <investigator_full_name>Ludhmila Abrahão Hajjar</investigator_full_name>
    <investigator_title>Professor of Cardiology, University of Sao Paulo</investigator_title>
  </responsible_party>
  <keyword>Intra-aortic balloon counterpulsation</keyword>
  <keyword>Cardiac surgery</keyword>
  <keyword>High-risk patients</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

